Organization: Ontario Genomics

The Short Report – March 9, 2022: Sunsetting the Collaborative Health Research Projects program, $195M to support B.C. health research, Ontario’s first Genome Data Science fellowships, Lululemon founder invests $100M into muscle disorder research, and more

CIHR and NSERC terminate Collaborative Health Research Projects program, BC’s government invests in life sciences to boost health research, Ontario Genomics and CANSSI Ontario award inaugural postdoctoral fellowships in genome data science, Lululemon founder gives $100 million for muscle disorder research, a strategy to make Manitoba a leader in sustainable protein production, and more.

Dr Marc Fortin

Dr Marc Fortin has been appointed VP research partnerships at the Natural Sciences and Engineering Research Council (NSERC), replacing Dr Bettina Hamelin who left the position in June to become president and CEO of Ontario Genomics. Fortin comes to NSERC from the Department of National Defence, where he held the dual roles of ADM S&T…

Genome Canada considers awarding grants directly to companies

Genome Canada may expand its successful Genomic Applications Partnership Program (GAPP) and award funds directly to companies with the in-house capacity to develop potentially disruptive technologies. The current GAPP program — which announced the results of its latest competition May 26 — only funds university researchers with industry partners, usually small firms that lack the in-house expertise to undertake research projects.

Dr Bettina Hamelin

Dr Bettina Hamelin has been appointed president and CEO of Ontario Genomics, replacing Dr Mark Poznansky who is leaving after nearly seven years in the positions. Hamelin will be responsible for overseeing and directing the agency’s genomics technology pipeline which to date has assisted 16 genomics firms to the “investor ready” stage of development and…

Ontario Genomics drops “Institute” from its name

The Ontario Genomics Institute has dropped the “Institute” from its name to reflect the evolving nature of its work. After 15 years of operation, Ontario Genomics (OG) is now solidly industry facing, focused on identifying and securing sources of financing to assist in research translation and commercialization. In addition to securing federal provincial and other…